Long-Term Debt (Quarterly)

Long-Term Debt: The sum of all long term debt fields.

Sanuwave Health Inc. (SNWV) had Long-Term Debt of $16.32M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$13.09M
Net Income	$6.11M
Cost of Goods Sold	$3.39M
Gross Profit	$9.70M
Operating Expenses	$12.48M
Operating Income	$0.61M
Non-Operating Income/Expense	$5.58M
Pre-Tax Income	$6.20M
Normalized Pre-Tax Income	$6.39M
Income after Taxes	$6.11M
Income from Continuous Operations	$6.11M
Consolidated Net Income/Loss	$6.11M
Normalized Income after Taxes	$6.31M
EBIT	$0.61M
EBITDA	$1.04M
Weighted-Average Shares Outstanding (Basic)	8.56M
Weighted-Average Shares Outstanding (Diluted)	9.08M
Earnings per Share (EPS) (Basic)	$0.72
Earnings per Share (EPS) (Diluted)	$0.60
Balance Sheet Financials
Current Assets	$24.63M
Property, Plant, and Equipment	$1.97M
Long-Term Assets	$12.72M
Total Assets	$37.34M
Current Liabilities	$17.85M
Long-Term Debt	$16.32M
Long-Term Liabilities	$17.88M
Total Liabilities	$35.72M
Common Equity	$1.62M
Tangible Shareholders Equity	$-8.67M
Shareholders Equity	$1.62M
Common Shares Outstanding	8.59M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.88M
Cash Flow from Investing Activities	$3.43M
Cash Flow from Financial Activities	$-5.59M
Beginning Cash	$10.24M
End Cash	$11.96M
Increase/Decrease in Cash	$1.72M
Stock-Based Compensation	$4.85M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.38
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.91
Debt to Equity Ratio	13.56
Gross Margin	74.09%
Operating Margin	4.70%
EBIT Margin	4.70%
EBITDA Margin	--
Pre-Tax Profit Margin	47.31%
Profit Margin	46.66%
Free Cash Flow	$7.31M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.35
Inventory Turnover	0.57
Receiveable Turnover	2.42
Days Sales in Receivables	37.27
Return on Equity	377.33%
Return on Tangible Equity	-70.49%
Return on Assets	16.36%
Return on Investments	34.05%
Book Value Per Share	$0.19
Free Cash Flow per Share	$0.80
Operating Cash Flow per Share	$0.43

Data from Zacks Investment Research, Inc.